Objective:To analyze the clinical features and long-term prognosis of ANCA-associated vasculitis (AAV) patients with different onset ages.Methods:A total of 243 patients diagnosed with AAV at the First Affiliated Hospital to Nanjing Medical University from May 2009 to January 2025 were retrospectively analyzed. The patients were divided into the elderly group (age≥60 years old) and middle-aged and young patient group (age<60 years old) according to the age of onset. The baseline clinical characteristics and long-term prognosis of the two groups were compared, and the risk factors for progression to end-stage renal disease (ESRD) in elderly AVV patients were analyzed. The clinical characteristics and long-term prognosis of the two groups of patients were compared. The measurement data were analyzed by t-test or rank sum test, and the count data were analyzed by chi-square test. The risk factors for the progression of ESRD in elderly patients with AAV were analyzed by binary multivariate logistic regression. Results:A total of 243 AAV patients were included, among which 174 cases were microscopic polyangiitis (MPA) and 69 cases were granulomatosis with polyangiitis (GPA). In 157 elderly patients, with 72 cases female, 84.1%(132 cases) had MPA. Compared with young and middle-aged patients, renal involvement is more common in elderly patients with AAV [(eldrly group 133 cases, 84.7%) vs. middle-aged and young patient group: 61 cases(70.9%), χ2=6.557, P=0.010]. The proportion of patients with hypertension, thrombosis, stroke, coronary heart disease, and COPD was higher compared to non-elder patients ( P<0.05). Elderly patients with AAV have higher levels of IgA and serum creatinine. Kaplan-Meier survival analysis showed that compared with young and middle-aged patients, elderly AAV patients had a higher all-cause mortality rate within 1 year after disease onset and a higher risk of progressing to ESRD within 1 year ( P<0.05), while the levels of IgM, C3, C4, albumin, and hemoglobin were lower ( P<0.05). 86 patients were middle-aged and young patients, with 54 cases were female and 51.2%(44 cases) had GPA. Ear, nose, and throat involvement was more common than elder patients[elderly group: 26 cases(16.2%) vs. middle-aged and young patient group: 31 cases(36.0%), χ2=10.864, P=0.001]. The median follow-up duration was 18 (7, 60) months. Kaplan-Meier survival analysis showed that compared with middle-aged and young patients, elderly AVV patients had a higher all-cause mortality rate within 1 year after disease onset and a higher risk of progression to ESRD within 1 year ( P<0.05). Multivariate logistic regression analysis revealed that baseline serum creatinine level [ OR(95% CI)=1.008(1.003, 1.012), P<0.001] was an independent risk factor for progression to ESRD in elderly patients. Conclusion:Elderly patients with AAV have more severe organ damage, higher all-cause mortality within one year, and a higher risk of progression to ESRD within one year after disease onset close monitoring of high-risk elderly patients should be strengthened.

Objective:To analyze the human immunodeficiency virus (HIV) screening status and the resulting residual risk (RR) among blood donors across 17 provincial blood centers in China.Methods:This study used a cross-sectional study. Data on HIV infection markers per 100 000 first-time donors (FD) and repeat donors (RD) from January 2015 to December 2024 were extracted from the National Blood Establishment Performance Comparison Information Management System. Questionnaires were used to collect each center′s HIV screening strategy, algorithm, serological test (ST) kit manufacturers, gray-zone setting for ST, and nucleic acid test (NAT) modality, method, and platform. The incidence-window-period model was used to calculate the residual risk for first-time donors (RR FD), repeat donors (RR RD), and total donors (RR TD) at each center. Horizontal and vertical analysis of RR FD, RR RD, and RR TD across centers and years were performed. Results:All 17 centers applied the same HIV screening strategy which was two rounds of ST followed by one round of NAT. Eight of them operated a single screening algorithm, six employed two algorithms and three used three. Eleven centers used both imported and domestic ST kits, five relied on domestic ST kits only, and one used imported ST kits only, while four centers never set a grey zone for ST throughout the decade. For NAT modalities, eight centers adopted both individual nucleic acid test (ID-NAT) and minipool nucleic acid test (MP-NAT), eight used MP-NAT only and one used ID-NAT only. Seven centers combined transcription mediated amplification (TMA) and polymerase chain reaction (PCR), nine used PCR only and one used TMA only, and fourteen centers ran both imported and domestic NAT systems, two used imported systems only and one used a domestic system only. Over the ten-year period, the mean RR FD across the centers ranged from 2.22 to 12.33 per 10 6 person-years, RR RD from 0.83 to 3.29 per 10 6 person-years and RR TD from 1.59 to 9.29 per 10 6 person-years, with center Z4 consistently showing the lowest values for all three metrics and center U4 recording the highest RR FD and RR TD, while center D2 had the highest RR RD. In 2024 compared with 2015, eleven centers achieved a lower RR FD and ten centers achieved lower RR RD and RR TD. The RR FD and RR TD of centers W2 and U4 displayed pronounced fluctuations and an upward trend in recent years. Conclusions:The 17 provincial blood centers maintain consistent HIV screening strategies, while demonstrating variations in screening algorithm, ST kit manufacturers, NAT modalities, methods, and platform. And the RR FD, RR RD, and RR TD differ across centers. Although most centers show declining trend in RR over the ten-year period, some centers exhibite data fluctuations with a rising trend, suggesting potential for further optimization of HIV screening protocols.

Objective:To analyze the clinical features and long-term prognosis of ANCA-associated vasculitis (AAV) patients with different onset ages.Methods:A total of 243 patients diagnosed with AAV at the First Affiliated Hospital to Nanjing Medical University from May 2009 to January 2025 were retrospectively analyzed. The patients were divided into the elderly group (age≥60 years old) and middle-aged and young patient group (age<60 years old) according to the age of onset. The baseline clinical characteristics and long-term prognosis of the two groups were compared, and the risk factors for progression to end-stage renal disease (ESRD) in elderly AVV patients were analyzed. The clinical characteristics and long-term prognosis of the two groups of patients were compared. The measurement data were analyzed by t-test or rank sum test, and the count data were analyzed by chi-square test. The risk factors for the progression of ESRD in elderly patients with AAV were analyzed by binary multivariate logistic regression. Results:A total of 243 AAV patients were included, among which 174 cases were microscopic polyangiitis (MPA) and 69 cases were granulomatosis with polyangiitis (GPA). In 157 elderly patients, with 72 cases female, 84.1%(132 cases) had MPA. Compared with young and middle-aged patients, renal involvement is more common in elderly patients with AAV [(eldrly group 133 cases, 84.7%) vs. middle-aged and young patient group: 61 cases(70.9%), χ2=6.557, P=0.010]. The proportion of patients with hypertension, thrombosis, stroke, coronary heart disease, and COPD was higher compared to non-elder patients ( P<0.05). Elderly patients with AAV have higher levels of IgA and serum creatinine. Kaplan-Meier survival analysis showed that compared with young and middle-aged patients, elderly AAV patients had a higher all-cause mortality rate within 1 year after disease onset and a higher risk of progressing to ESRD within 1 year ( P<0.05), while the levels of IgM, C3, C4, albumin, and hemoglobin were lower ( P<0.05). 86 patients were middle-aged and young patients, with 54 cases were female and 51.2%(44 cases) had GPA. Ear, nose, and throat involvement was more common than elder patients[elderly group: 26 cases(16.2%) vs. middle-aged and young patient group: 31 cases(36.0%), χ2=10.864, P=0.001]. The median follow-up duration was 18 (7, 60) months. Kaplan-Meier survival analysis showed that compared with middle-aged and young patients, elderly AVV patients had a higher all-cause mortality rate within 1 year after disease onset and a higher risk of progression to ESRD within 1 year ( P<0.05). Multivariate logistic regression analysis revealed that baseline serum creatinine level [ OR(95% CI)=1.008(1.003, 1.012), P<0.001] was an independent risk factor for progression to ESRD in elderly patients. Conclusion:Elderly patients with AAV have more severe organ damage, higher all-cause mortality within one year, and a higher risk of progression to ESRD within one year after disease onset close monitoring of high-risk elderly patients should be strengthened.

Objective:To analyze the human immunodeficiency virus (HIV) screening status and the resulting residual risk (RR) among blood donors across 17 provincial blood centers in China.Methods:This study used a cross-sectional study. Data on HIV infection markers per 100 000 first-time donors (FD) and repeat donors (RD) from January 2015 to December 2024 were extracted from the National Blood Establishment Performance Comparison Information Management System. Questionnaires were used to collect each center′s HIV screening strategy, algorithm, serological test (ST) kit manufacturers, gray-zone setting for ST, and nucleic acid test (NAT) modality, method, and platform. The incidence-window-period model was used to calculate the residual risk for first-time donors (RR FD), repeat donors (RR RD), and total donors (RR TD) at each center. Horizontal and vertical analysis of RR FD, RR RD, and RR TD across centers and years were performed. Results:All 17 centers applied the same HIV screening strategy which was two rounds of ST followed by one round of NAT. Eight of them operated a single screening algorithm, six employed two algorithms and three used three. Eleven centers used both imported and domestic ST kits, five relied on domestic ST kits only, and one used imported ST kits only, while four centers never set a grey zone for ST throughout the decade. For NAT modalities, eight centers adopted both individual nucleic acid test (ID-NAT) and minipool nucleic acid test (MP-NAT), eight used MP-NAT only and one used ID-NAT only. Seven centers combined transcription mediated amplification (TMA) and polymerase chain reaction (PCR), nine used PCR only and one used TMA only, and fourteen centers ran both imported and domestic NAT systems, two used imported systems only and one used a domestic system only. Over the ten-year period, the mean RR FD across the centers ranged from 2.22 to 12.33 per 10 6 person-years, RR RD from 0.83 to 3.29 per 10 6 person-years and RR TD from 1.59 to 9.29 per 10 6 person-years, with center Z4 consistently showing the lowest values for all three metrics and center U4 recording the highest RR FD and RR TD, while center D2 had the highest RR RD. In 2024 compared with 2015, eleven centers achieved a lower RR FD and ten centers achieved lower RR RD and RR TD. The RR FD and RR TD of centers W2 and U4 displayed pronounced fluctuations and an upward trend in recent years. Conclusions:The 17 provincial blood centers maintain consistent HIV screening strategies, while demonstrating variations in screening algorithm, ST kit manufacturers, NAT modalities, methods, and platform. And the RR FD, RR RD, and RR TD differ across centers. Although most centers show declining trend in RR over the ten-year period, some centers exhibite data fluctuations with a rising trend, suggesting potential for further optimization of HIV screening protocols.

Objective To explore the value of contrast-enhanced ultrasound(CEUS)in the assessment of diabetic microangiopademia through evaluating microcirculation perfusion of triceps surae muscle by CEUS.Method Totally 51 patients with type 2 diabetes mellitus(T2DM)admitted in our hospital between August 2020 and January 2023 were collected,including 15 pure T2DM patients and 36 T2DM patients complicated with microcirculatory disturbance(T2DM+CM).Each patient's hemoglobin A1c(HbA1c)and homeostatic model assessment for insulin resistance(HOMA-IR)were recorded.After getting enhanced intensity(PI-BI)and regional peak time(TTP-AT)by CEUS,comparative analysis between groups was conducted.Results The levels of HbA1c and HOMA-IR in T2DM+CM group were higher than those in pure T2DM group(P<0.05).TTP-AT in T2DM+CM group were longer than that in pure T2DM group of all muscles musculi gastrocnemii(MG),laterale musculi gastrocnemi(LG),soleus(SOL)and triceps surae muscle's junction region)(P<0.05).The TTP-AT of SOL was longest in both groups,followed by LG,and MG(P<0.05).The PI-BI had no significant difference among MG,LG and SOL in pure T2DM group.The PI-BI of MG was higher than that of SOL in the T2DM+CM group(P<0.05).TTP-AT of triceps surae muscle's junction region had significant positive association with both HbA1c and HOMA-IR(P<0.05).Conclusion The TTP-AT of triceps surae muscle measured by CEUS is a new indicator for evaluating microangiopathopathy in T2DM patients.

Pulmonary sarcomatoid carcinoma(PSC)is a rare and highly malignant tumor,which includes the follow-ing five pathologic types:pleomorphic carcinoma,spindle cell carcinoma,giant cell carcinoma,carcinosarcoma and pulmonary blastoma.The onset of PSC is occult with non-specific clinical symptoms and signs.The clinical manifestations include irritat-ing cough,bloody sputum,dyspnea,chest pain and so on,which are closely related to the growth and invasion site of the tumor.PSC tends to metastasize early,so most patients are already in local advanced stage or advanced stage with a median survival of 9 months at the time of hospital visit.A patient with primary PSC which led to 90%stenosis in central airway was treated by com-bined method of vascular and tracheoscopic intervention in our respiratory center.This treatment prolonged the patient's survival time and got a satisfactory effect at 19-month follow-up after surgery.Herein we report the case for clinical reference.

Background and objective As a new technique developed in recent years,bronchoscopic interven-tion therapy has the advantages of minimal invasion,high safety and repeatability.The aim of this study is to investigate the clinical characteristics of bronchopleural fistula(BPF)induced by surgeries for lung malignancies or benign diseases and the effect of bronchoscopic intervention therapy for BPF,so as to provide support for prevention and treatment of BPF.Methods Data 64 patients with BPF who were treated by bronchoscopic intervention in Respiratory Disease Cen-ter of Dongzhimen Hospital,Beijing University of Chinese Medicine from June 2020 to September 2023 were collected.Patients with fistula diameter ≤5 mm were underwent submucous injection of macrogol,combined with blocking therapy with N-butyl cyanoacrylate,medical bioprotein glue or silicone prosthesis.Patients with fistula diameter＞5 mm were im-planted with different stents and cardiac occluders.Locations and characteristics of fistulas were summarized,meanwhile,data including Karnofsky performance status(KPS),shortbreath scale(SS),body temperature,pleural drainage volume and white blood cell count before and after operation were observed.Results For all 64 patients,96 anatomic lung resections in-cluding pneumonectomy,lobectomy and segmentectomy were executed and 74 fistulas occurred in 65 fistula locations.The proportion of fistula in the right lung(63.5％)was significantly higher than that in the left(36.5％).Besides,the right inferior lobar bronchial fistula was the most common(40.5％).After operation,KPS was significantly increased,while SS,body tem-perature,pleural drainage volume and white blood cell count were significantly decreased compared to the preoperative values(P＜0.05).By telephone follow-up or readmission during 1 month to 38 months after treament,median survival time was 21 months.33 patients(51.6％)showed complete response,7 patients(10.9％)showed complete clinical response,18 patients(28.1％)showed partial response,and 6 patients(9.4％)showed no response.As a whole,the total effective rate of broncho-scopic intervention for BPF was 90.6％.Conclusion BPF induced by pulmonary surgery can lead to severe symptoms and it is usually life-threating.Bronchoscopic intervention therapy is one of the fast and effective therapeutic methods for BPF.

Pulmonary mixed squamous cell and glandular papilloma(MSCGP)is a subtype of pulmonary papil-loma,which can be classified as central type and peripheral type based on its site of development.The central type is the most common.The clinical manifestations of pulmonary MSCGP are mainly related to the location of the tumor.Surgery is the main treatment for this disease.Bronchoscopic interventional treatment for the MSCGP in the central trachea could receive satis-factory effect.We reported a patient suffered from diffuse tracheal MSCGP who was treated by bronchoscopic interventional treatment in Respiratory Disease Center,Dongzhimen Hospital of Beijing University of Chinese Medicine,aiming to enhance the recognition of the clinical features and provide clinical references for the diagnosis and treatment of such disease.

Objective To explore the concentration of serum placental alkaline phosphatase in cervical cancer patients and its potential clinical application value.Methods Fifty-three cervical cancer patients who received treatment in Department of Gynaecology and Obstetrics,the First Hospital of Nanchang from January 2023 to February 2024 were selected retrospectively as cervical cancer group,and fifty-three women who underwent physical examination were selected as health control group during the same period.The concentration of serum placental alkaline phosphatase levels and serum total alkaline phosphatase activity between two groups above were detected and compared.Results The level of serum placental alkaline phosphatase of patients in cervical cancer group were higher than that in health control group(t=53.461,P<0.001),and the activity of serum total alkaline phosphatase was lower than that in health control group(t=9.910,P<0.001).Conclusion The elevated levels of serum placental alkaline phosphatase in cervical cancer patients may be related to their condition.

Objective To explore the concentration of serum placental alkaline phosphatase in cervical cancer patients and its potential clinical application value.Methods Fifty-three cervical cancer patients who received treatment in Department of Gynaecology and Obstetrics,the First Hospital of Nanchang from January 2023 to February 2024 were selected retrospectively as cervical cancer group,and fifty-three women who underwent physical examination were selected as health control group during the same period.The concentration of serum placental alkaline phosphatase levels and serum total alkaline phosphatase activity between two groups above were detected and compared.Results The level of serum placental alkaline phosphatase of patients in cervical cancer group were higher than that in health control group(t=53.461,P<0.001),and the activity of serum total alkaline phosphatase was lower than that in health control group(t=9.910,P<0.001).Conclusion The elevated levels of serum placental alkaline phosphatase in cervical cancer patients may be related to their condition.